A mathematician explains the important difference between absolute risk and relative risk.
Academic rigor, journalistic flair
Articles on COVID-19 vaccine risks
Displaying all articles
Whether about a comet hitting the Earth or a virus infecting the world, fear-based messages often do not succeed at changing people’s behaviors.
In some cases, fever reducers and extra fluid intake can weaken the body’s response to infection.
Myocarditis following COVID-19 vaccination is rare, and the risk is much smaller than the risks of cardiac injury linked to COVID-19 itself.
The circulation of misinformation about the COVID-19 vaccine poses the danger of hampering the government’s efforts to control the pandemic.
What do you need to weigh up when working out whether to get the AstraZeneca vaccine? Here’s what the evidence says.
Our brains cannot easily understand tiny risks so we tend to overestimate them. That’s when we need a little extra help to make the best decisions about our health.
As vaccine eligibility is expanded to adolescents and young adults, understanding who might be more likely to be vaccine hesitant, and why, can help inform public health strategies
The CDC first paused, then unpaused, the administration of the Johnson & Johnson COVID-19 vaccine due to concerns about blood clots. But what are those clots, and how do they form?
The AstraZeneca COVID vaccine is now available to Australians over 50. Here’s what you need to know before you roll up your sleeve.
It’s normal for different people to mount stronger or weaker immune responses to a vaccine, but post-shot side effects won’t tell you which you are.
If one adenoviral vaccine is linked with blood clots, it doesn’t mean all vaccines in this family will have that same effect. But it’s definitely worth health authorities assessing the data.
The one-dose vaccine developed by Johnson & Johnson is temporarily halted because of potentially serious blood clots seen in six women. An immunologist explains what this means for you.
Pausing COVID-19 vaccine rollouts can backfire. There are better ways to manage safety issues while they’re being investigated.
We already track potential vaccine side-effects in Australia. So we’ll be using, and building on, years of experience in monitoring any long-term effects of COVID-19 vaccines.
The arrival of COVID-19 vaccines has raised hope for an end to the pandemic. Hopefully that’s true, but there are variables. Here are some factors that could affect the success of the vaccine rollout.
By prioritising vaccination for the elderly, Indonesia may optimally reduce the hospital burden and COVID-19 deaths amid a limited vaccine supply during the first vaccination phase.
Now that two COVID vaccines have been authorized by the FDA, questions arise. Today, a physician from Indiana University School of Medicine answers five reader questions.
A serious allergic reaction was reported in a health care worker in Alaska after she received the COVID-19 vaccine. Does this mean that people with allergies need to be concerned? An expert answers.
Top contributors
-
Professor of Paediatrics and vaccinologist, Royal Childrens Hospital, University of Melbourne and Murdoch Childrens Research Institute (MCRI); Associate Dean International, University of Melbourne, Murdoch Children's Research Institute
-
Associate Professor, Pharmaceutical Sciences, University of KwaZulu-Natal
-
Research Fellow at the Faculty of Medicine, Universitas Mataram
-
Associate Professor of Exercise and Sports Science, Wayne State University
-
Associate Professor, Epidemiology, Deakin University
-
Professor of Medicine, UMass Chan Medical School
-
Member, IMPART (Inflammation & Metabolism, Physical Ability, & Research Translation) Network, Dalhousie University
-
General Practitioner, PhD Candidate, Bond University
-
Professor of Communication Arts and Sciences, Penn State
-
Applied Statistician, Eijkman-Oxford Clinical Research Unit (EOCRU)
-
PhD candidate in Biomaterials and Tissue Engineering, UCL
-
Vice-Chancellor's Research Fellow, School of Health and Biomedical Sciences, RMIT University
-
Senior Lecturer, Department of Pharmacy and Pharmacology, University of the Witwatersrand
-
Associate Professor and Epidemiologist, Infectious Diseases, Immunisation and Emergencies Group, Sydney School of Public Health, University of Sydney
-
Research Associate in Community Health Sciences, University of Manitoba
